NFKB1 and Patent ductus arteriosus: Previous studies support this notion and demonstrate that inactivation of the NF-κB pathway effectively prevents the formation of human orthotopically transplanted PDA xenografts in mice [30] and the formation of inflammation/colitis-associated cancer in a mouse model [42].